---
gsd_state_version: "1.0"
milestone: v1.26
milestone_name: Pre-Adopter Readiness & Quality Consolidation
status: in_progress
stopped_at: Executing Phase 138; plans 01–03 complete, starting plan 04
last_updated: "2026-10-22T03:36:53.672426+00:00"
state_head: 007c994985f35f48f227cbe56c8a7137b3461882
progress:
  total_phases: 7
  completed_phases: 5
  total_plans: 225
  completed_plans: 222
  percent: 71
last_activity: 2026-10-21
current_phase: 138
current_phase_name: Lifecycle Failure and Recovery Matrix
current_plan: 138-04 executing; 3/6 executed
last_activity_desc: "138-01 through 138-03 committed and summarized; real tus/purge/AV cases and separate verifiers pass. Starting 138-04. Full matrix and all RECOV acceptance remain pending."
---

## Project Reference

See: .planning/PROJECT.md (updated 2026-10-21).
**Core value:** Media, made durable.
**Current focus:** Phase 138 — Lifecycle Failure and Recovery Matrix (executing; 3/6 plans complete).
**Worktree:** /Users/jon/projects/rindle/.claude/worktrees/phase136-execution
The primary checkout retains separate historical Phase 133 work; preserve it.

## Current Position

Phase 137 is complete: six plans, twelve tasks, 22/22 must-haves and TWIN-01..06
verified automatically. All plan summaries, validation, security, code review,
review disposition and goal verification are committed or ready for close-out.
The verification owner reports passed with a current covered-input fingerprint.
Progress: 5/7 phases complete (71%); 222/225 currently planned plans complete.
Phase 138 discussion is complete: local GSD assumptions analysis, three primary-source
researchers and an independent adversarial pass informed the approved context. The user
approved the full six-case matrix and bounded correctness fixes if adverse provider probes
confirm stale-event regression or duplicate effects, preserving public API/schema. Doctor's
ledger fix remains for Phase 139. Context and research recommendations are in
`.planning/phases/138-lifecycle-failure-and-recovery-matrix/`.
Phase 138 planning is complete: implementation research, pattern map, draft validation
strategy, API coverage and six executable plans cover RECOV-01..06 and D-138-01..18.
Thirteen tasks run in six sequential waves because shared harness files overlap.
Independent checking resolved the research questions, red-only task verification and
file-scope reviews. Provider timestamp/polling semantics are specified; the first named
regression and its fix complete in one red-to-green task. The AV case starts with a
finite 600-second deadline. Broad provider/cleanup file scopes have explicit ownership
and stop/rescope conditions. All 21 verify commands state failure signals; their path
probe was not applicable to these command forms and grants no positive path proof.
Phase 138 plans 01–03 are executed and summarized; plans 04–06 remain. Phase 139 remains unplanned. RECOV-01..06 receive no
acceptance credit. Draft validation stays unvalidated pending executable evidence.

Full stable default suite: 1717 tests plus 3 doctests, zero failures, 87 excluded,
4 skipped. After final isolation fixes: 63 focused twin/async/CI/public-surface
tests, zero failures. Final real acceptance subject: 4e41e644. Native build output
proves uncached Rindle compilation from the single fresh archive. The actual
retry/restart trace, separate retained-inputs verifier and repeated stopped-host
cleanup passed; real active/paused cleanup controls preserved owned storage.
Evidence: /private/tmp/rindle-twin-137-accepted-9hf_wi4o. Observed local real-run
runtime 55.63 seconds; no numeric CI timing credit. No new CI lane, public library
API/dependency, pilot, AV execution, readiness, merge or release claim.

## Next GSD Command

Run `$gsd-execute-phase 138` now in
`/Users/jon/projects/rindle/.claude/worktrees/phase136-execution` to resume from the first unsummarized plan if interrupted. No need to re-run completed plans.
Give direct stage commands when the next action is known; do not repeatedly route
the user through `$gsd-progress`. No conversation reset is required; preserve the
ordinary GSD workflow, approved context and existing plans.
Auto-advance remains disabled. Serious work remains on this feature branch; use
normal PR/green-main gates before merging or releasing.

## Decisions and Verification Debt

- Dedicated minimal external Phoenix/Repo/default-Oban host supersedes the earlier
  Cohort-centered assumption; Cohort and existing smoke semantics remain intact.
- Doctor's legacy-package/host migration-ledger comparison falsely fails for the
  supported versioned host. Pending todo: 2026-10-21-doctor-versioned-host-migration-ledger.md.
  Twin acceptance uses direct supported catalog/version/real-I/O checks; no Doctor pass.
- Numeric CI speed target remains deferred unfinished to SEED-261021-918 with zero
  credit. Do not collect or wait for it here. Historical failed/blocked receipts remain.
- PR 162 was already squash merged and its PR/main CI passed; this phase is not yet
  merged and no release action was taken.
- Older Phase 133–136 covered-input fingerprints can be stale after shared source,
  docs or config changes. Retain this audit debt. The full default regression passed;
  never rewrite old fingerprints or replay consumed qualification authorizations.
- The existing Phase 136 external measurement job was reconciled and closed by its
  committed summary; do not resubmit it. Its historical accepted coverage was
  5206/6329; no new coverage-floor measurement was taken in Phase 137.
- User approved unused Docker build-cache cleanup; 4.524 GB reclaimed. No unrelated
  containers, volumes or tagged images were removed. This was environment approval,
  not acceptance evidence. There is no pending approval.
- Preserve model routing and .tool-versions. Canonical checks use Elixir 1.17.3 /
  OTP 27.3.4.15 / Node 20.18.1 environment overrides. No independent-adopter credit.

## Session

Last session: 2026-10-22T02:50:00.432Z
Stopped at: Executing Phase 138 plan 04; 3/6 plans complete
Resume file: .planning/phases/138-lifecycle-failure-and-recovery-matrix/138-04-PLAN.md
